Ofer Lifshitz - ICL Israel President, ICL Phosphate Solutions Division
| ICL Stock | ILA 1,780 14.00 0.78% |
President
Mr. Ofer Lifshitz serves as President, ICL Phosphate Solutions Division of the Company. Mr. Lifshitz joined ICL in 1996 and served in various senior leadership positions including Executive Vice President of ICL Industrial Products, Senior Vice President of Global Processes and as the companys Integration Manager, Executive Vice President for Special Projects, and until recently, President of ICL Essential Minerals Division since 2018.
| Age | 61 |
| Tenure | 6 years |
| Phone | (972) 3 684 4427 |
| Web | www.icl-group.com |
ICL Israel Management Efficiency
The company has return on total asset (ROA) of 0.1916 % which means that it generated a profit of $0.1916 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4322 %, meaning that it generated $0.4322 on every $100 dollars invested by stockholders. ICL Israel's management efficiency ratios could be used to measure how well ICL Israel manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Brendan OGrady | Teva Pharmaceutical Industries | 52 | |
| Sven Dethlefs | Teva Pharmaceutical Industries | 54 | |
| Ofer Levy | Bank Hapoalim | 65 | |
| Zeev Gofer | Elbit Systems | 66 | |
| Amir Nachlieli | Bezeq Israeli Telecommunication | 56 | |
| Eti BenZeev | Bank Hapoalim | 56 | |
| Ronen Stein | Bank Hapoalim | 51 | |
| Amir Bachar | Bank Hapoalim | 51 | |
| Yadin Antebi | Bank Hapoalim | 53 | |
| Jonathan Ariel | Elbit Systems | 62 | |
| Yael Almog | Bank Hapoalim | 55 | |
| Ran Kril | Elbit Systems | 52 | |
| Gianfranco Nazzi | Teva Pharmaceutical Industries | 50 | |
| Ilan Pacholder | Elbit Systems | 64 | |
| Shelly Gordon | Elbit Systems | 58 | |
| Hafrun Fridriksdottir | Teva Pharmaceutical Industries | 57 | |
| David Stark | Teva Pharmaceutical Industries | 54 | |
| Yuval Ramon | Elbit Systems | 57 | |
| Ofer Koren | Bank Hapoalim | 47 | |
| Richard Daniell | Teva Pharmaceutical Industries | 52 | |
| David Temin | Elbit Systems | 67 | |
Management Performance
| Return On Equity | 0.43 | |||
| Return On Asset | 0.19 |
ICL Israel Chemicals Leadership Team
Elected by the shareholders, the ICL Israel's board of directors comprises two types of representatives: ICL Israel inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ICL. The board's role is to monitor ICL Israel's management team and ensure that shareholders' interests are well served. ICL Israel's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ICL Israel's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Raviv Zoller, Chief Executive Officer | ||
| Nitzan Moshe, Executive Vice President - Global Operations | ||
| Tzipi OzerArmon, Independent Director | ||
| Lilach GevaHarel, Senior Vice President and Global General Counsel | ||
| Avisar Paz, Director | ||
| Yoav Doppelt, Executive Chairman of the Board | ||
| Ilana Fahima, Executive Vice President ICL Global Human Resources | ||
| Ido Lilian, Executive Vice President-Global Procurement | ||
| Reem Aminoach, Independent Director | ||
| Ruth Ralbag, External Independent Director | ||
| Noam Goldstein, President - Potash Division | ||
| Anantha Desikan, Executive Vice President Chief Innovation & Technology Officer | ||
| Maya Grinfeld, VP Communications | ||
| Aviram Lahav, Chief Officer | ||
| Aya Landman, Company VP | ||
| Ofer Lifshitz, President, ICL Phosphate Solutions Division | ||
| Lior Reitblatt, Independent Director | ||
| Nadav Kaplan, Independent Director | ||
| Kobi Altman, CFO, Executive Vice President | ||
| Anat TalKtalav, President ICL Industrial Products Division | ||
| Eli Amon, Executive Vice President ICL Innovative Ag Solutions Division | ||
| Aviad Kaufman, Director | ||
| Miri Mishor, Senior Vice President - ICL Global Information Technology | ||
| Ovadia Eli, External Director | ||
| Amir Meshulam, Senior Vice President Global Internal Auditor | ||
| Advocate GevaHarel, Exec Counsel | ||
| Elad Aharonson, Pres Solutions | ||
| Sagi Kabla, Director |
ICL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ICL Israel a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.43 | |||
| Return On Asset | 0.19 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.34 % | |||
| Current Valuation | 43.75 B | |||
| Shares Outstanding | 1.29 B | |||
| Shares Owned By Insiders | 44.90 % | |||
| Shares Owned By Institutions | 25.12 % | |||
| Price To Book | 2.00 X | |||
| Price To Sales | 3.31 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for ICL Stock analysis
When running ICL Israel's price analysis, check to measure ICL Israel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICL Israel is operating at the current time. Most of ICL Israel's value examination focuses on studying past and present price action to predict the probability of ICL Israel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICL Israel's price. Additionally, you may evaluate how the addition of ICL Israel to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |